Researchers / academia

Europe: the EU Cardiovascular Health Plan is becoming the “cancer plan” moment for heart disease

A new Lp(a) threshold could reshape cardiovascular risk assessment

Oral SERDs Face the Hard Test: Where Do They Actually Fit?

The ASCO Drug Race Still Runs Through Genomic Testing

Alzheimer’s Blood Testing Moves the Disease Clock Earlier

Physical activity continues to strengthen its case as a cross-disease prevention strategy

Can cortisol become the next target in type 2 diabetes?

The Air We Breathe May Be Shaping the Future Burden of Blindness

AI Pathology Starts Moving Toward Treatment Selection
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
